Joyce Varughese, MD
Gynecologic Oncology · Pennington, NJNPI 1326222589
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 63.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $11,056, 2.4 times the $4,645 reported in 2019. Among gynecologic oncology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $799.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$10K
- Merck$5K
- Histosonics, Inc.$824
- Intuitive Surgical$129
- E.r. Squibb & Sons, L.L.C.$125
- GSK$103
- plus $66 from 3 others
What the payments were for
- Consulting fees$9,20258%
- Speaking & faculty fees$3,50022%
- Travel & lodging$2,63116%
- Food & beverage$6524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 9 | $10,182 |
| Merck | 3 | $4,556 |
| Histosonics, Inc. | 1 | $824 |
| Intuitive Surgical | 2 | $129 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| GSK | 1 | $103 |
| Conmed Corporation | 1 | $34 |
| Ambu Inc. | 1 | $17 |
| Genmab U.S., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL$4,539
- Reblozyl$125
- Surgicel Powder$106
- JEMPERLI$103
How this compares
$15,985 in reported general payments places this provider in the 95th percentile of 45 gynecologic oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 23 | $19 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Pennington
- Mona SalehPennington$250
- Sharyn LewinTeaneck$968K
- Scott RichardFlorham Park$84K
- James BosscherNeptune$13K
- Daniel TobiasMorristown$11K
- Karim ElsahwiNeptune$11K
- William BurkeParamus$9K
- Maria Schiavone ForlenzaTeaneck$8K
- Thad DenehyWest Orange$5K
- Shannon TomitaMorristown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.